Research Article
Evaluation of the Quality of Life of Diabetics at the National Reference University Hospital Center (CHU-RN) of N'Djamena
Daboulaye Allah-Sayim Desire*
,
Oumar Abba,
Nafissatou Ali Ouani Makang,
Tidjani Abdelsalam,
Habiba Abdoulaye Affadine,
Adjougoulta Koboy Bonte,
Mouandilmadji Djikoldinguem Marschall,
Zakaria Abdel-Madjid Zakaria,
Ali Mahamat Moussa,
Bessimbaye Nadlaou
Issue:
Volume 11, Issue 2, June 2026
Pages:
13-19
Received:
11 May 2026
Accepted:
25 May 2026
Published:
18 June 2026
Abstract: Diabetes mellitus, a chronic disease, significantly impairs quality of life. In Chad, data on this subject are scarce. This study evaluates the quality of life of diabetic patients followed at the National Reference University Hospital of N'Djamena, using the ADDQOL questionnaire. To assess the QoL of diabetics and identify the factors that can influence it. A cross-sectional and analytical study was conducted with 130 diabetic patients (types 1 and 2) during consultations. The ADDQOL questionnaire was used to assess the impact of diabetes on several aspects of life. A weighted score (impact × importance) was calculated and analyzed. In total, we collected data on 130 diabetic patients. The mean age of the patients was 40.93 ± 12.3 years, with a range from 36 to 65 years. Males were predominant, with a male-to-female ratio of 1.2. The overall weighted score was -2.56, indicating moderate to severe impairment. The most affected areas were: dietary freedom (-4.57), drinking (-4.18), finances (-3.67), work (-3.63), and sexuality (-3.13). Other aspects, such as physical appearance and self-confidence, were also affected. Unlike other variables significantly associated with impaired quality of life—low socioeconomic status, diabetes duration ≥ 5 years, insulin therapy, oral antidiabetic drug use, diabetic foot, hypoglycemia, acidosis, and type 1 diabetes—type 2 diabetes did not show a statistically significant association in our analysis (OR = 2.13; 95% CI: 0.76–5.93; p = 0.138). Diabetes affects various aspects of life, including independence, social life, and intimate relationships. These findings highlight the need to integrate quality of life assessment into patient care, along with appropriate psychological, nutritional, and social support.
Abstract: Diabetes mellitus, a chronic disease, significantly impairs quality of life. In Chad, data on this subject are scarce. This study evaluates the quality of life of diabetic patients followed at the National Reference University Hospital of N'Djamena, using the ADDQOL questionnaire. To assess the QoL of diabetics and identify the factors that can inf...
Show More
Research Article
Clinicians' Perspectives on Glycemic Control, Treatment Strategies, and Monitoring in Type 2 Diabetes Mellitus:
A Nationwide Survey
Manjula Suresh*,
Krishna Kumar Manjunath
Issue:
Volume 11, Issue 2, June 2026
Pages:
20-27
Received:
18 May 2026
Accepted:
29 May 2026
Published:
27 June 2026
DOI:
10.11648/j.ijde.20261102.12
Downloads:
Views:
Abstract: Background: Although there are several clinical studies available regarding the management of Type 2 diabetes mellitus (T2DM), there is a dearth of studies among clinical experts on their practice. This study aimed to assess clinicians’ perspectives on the drivers of poor glycemic control, gaps in early screening, treatment choices, use of fixed-dose combinations (FDCs) of dapagliflozin, glimepiride, and metformin, safety considerations, and perceived glycemic outcomes in T2DM. Methodology: This cross-sectional study was carried out among 1,300 Indian clinical experts and utilized a multiple-response questionnaire to assess perspectives on poor glycemic control, screening gaps, and treatment patterns related to FDCs of dapagliflozin, glimepiride, and metformin. Responses were summarized using descriptive statistics and visualized using Microsoft Excel. Results: More than half of the participants (54.46%) identified a sedentary lifestyle and irregular follow-up visits as the principal contributors to poor glycemic control in routine clinical practice. A substantial majority (68.77%) indicated that inadequate awareness of early screening is the primary reason for elevated glycated hemoglobin (HbA1c) levels at diagnosis. Over half of the respondents (52.23%) perceived sulfonylureas to provide superior glycemic durability in clinical settings. Approximately 42% reported multiple factors, namely rapid and sustained glycemic control, reduced pill burden, and cost considerations, as key reasons for the early initiation of combination therapy. Nearly two-thirds of clinicians (63.46%) observed that patients with high baseline HbA1c levels (8–11%) experience the greatest benefit from the FDCs of dapagliflozin, glimepiride, and metformin. Conclusion: Uncontrolled T2DM is primarily driven by a sedentary lifestyle, poor follow-up, and low awareness of early screening. Clinicians favor sulfonylureas for glycemic durability and support early combination therapy for rapid control, improved adherence, and cost considerations. FDCs are perceived to delay insulin initiation, with patients presenting with high baseline HbA1c levels deriving the greatest benefit from the combination of dapagliflozin, glimepiride, and metformin.
Abstract: Background: Although there are several clinical studies available regarding the management of Type 2 diabetes mellitus (T2DM), there is a dearth of studies among clinical experts on their practice. This study aimed to assess clinicians’ perspectives on the drivers of poor glycemic control, gaps in early screening, treatment choices, use of fixed-do...
Show More
